Q2 2016 Holdings
Filed 2016-08-01 | 97 holdings | $52.6M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↑ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Threshold Pharmaceuticals | COM | 885807206 | $128 | 201,537 | 0.0% |
| Glaukos Corp(GKOS) | COM | 377322102 | $149 | 5,100 | 0.0% |
| Ocular Therapeutix Inc(OCUL) | COM | 67576A100 | $198 | 40,000 | 0.0% |
| Mirati Therapeutics Inc(MRTXEUR) | COM | 60468T105 | $273 | 50,000 | 0.0% |
| Concert Pharm Inc(CNCEEUR) | COM | 206022105 | $338 | 30,099 | 0.0% |
| Adverum Biotechnologies Inc(ADVMCHF) | COM | 00773U108 | $487 | 154,006 | 0.0% |
| Ultragenyx Pharmaceutical Inc(RARE) | COM | 90400D108 | $489 | 10,000 | 0.0% |
| Orexigen Therapeutics Inc | COM | 686164104 | $516 | 1,200,000 | 0.0% |
| Quorum Health Corp | COM | 74909E106 | $602 | 56,250 | 0.0% |
| Anthera Pharmaceuticals Inc | COM | 03674U201 | $927 | 300,000 | 0.0% |
| Regulus Therapeutic Inc | COM | 75915K101 | $1.0K | 350,000 | 0.0% |
| Catabasis Pharmaceuticals Inc | COM | 14875P107 | $1.3K | 345,100 | 0.0% |
| Tetraphase Pharmaceuticals Inc | COM | 88165N105 | $1.3K | 300,000 | 0.0% |
| Array BioPharma Inc(ARRYEUR) | COM | 04269X105 | $1.3K | 370,000 | 0.0% |
| Esperion Therapeutics Inc(ESPR) | COM | 29664W105 | $1.4K | 140,000 | 0.0% |
| Tandem Diabetes Care Inc | COM | 875372104 | $1.6K | 209,000 | 0.0% |
| Perrigo Co Plc(PRGO) | SHS | G97822103 | $1.8K | 20,000 | 0.0% |
| Neurocrine Biosciences Inc(NBIX) | COM | 64125C109 | $1.8K | 40,000 | 0.0% |
| FibroGen Inc(FGENEUR) | COM | 31572Q808 | $1.9K | 114,000 | 0.0% |
| Rigel Pharmaceuticals Inc(RIGLUSD) | COM | 766559603 | $1.9K | 850,000 | 0.0% |
| Adamas Pharmaceuticals Inc(ADMSEUR) | COM | 00548A106 | $2.0K | 130,000 | 0.0% |
| Achillion Pharmaceuticals Inc(ACHNEUR) | COM | 00448Q201 | $2.1K | 266,000 | 0.0% |
| Halozyme Therapeutics Inc(HALO) | COM | 40637H109 | $2.2K | 250,000 | 0.0% |
| Chimerix Inc(CMRXEUR) | COM | 16934W106 | $2.2K | 550,000 | 0.0% |
| Dynavax Technologies Corp(DVAX) | COM | 268158201 | $2.2K | 150,000 | 0.0% |
| NeuroDerm Ltd | SHS | M74231107 | $2.3K | 144,546 | 0.0% |
| Portola Pharmaceuticals Inc | COM | 737010108 | $2.5K | 105,000 | 0.0% |
| Insulet Corp(PODD) | COM | 45784P101 | $2.5K | 82,000 | 0.0% |
| Becton Dickinson & Co(BDX) | COM | 075887109 | $2.5K | 15,000 | 0.0% |
| Cempra Inc | COM | 15130J109 | $2.8K | 171,000 | 0.0% |
| Keryx Biopharmaceuticals Inc | COM | 492515101 | $3.0K | 450,111 | 0.0% |
| Revance Therapeutics Inc(RVNCEUR) | COM | 761330109 | $3.0K | 220,000 | 0.0% |
| NxStage Medical Inc | COM | 67072V103 | $3.2K | 145,300 | 0.0% |
| Abbott Laboratories(ABT) | COM | 002824100 | $3.3K | 84,100 | 0.0% |
| Kite Pharma Inc | COM | 49803L109 | $3.5K | 70,000 | 0.0% |
| Livanova Plc(LIVN) | SHS | G5509L101 | $3.5K | 70,000 | 0.0% |
| Radius Health Inc | COM | 750469207 | $3.7K | 100,000 | 0.0% |
| Macrogenics Inc(MGNX) | COM | 556099109 | $3.8K | 140,000 | 0.0% |
| Nevro Corp(NVROEUR) | COM | 64157F103 | $4.0K | 54,300 | 0.0% |
| Valeant Pharm Intl Inc | COM | 91911K102 | $4.2K | 210,000 | 0.0% |
| Xencor Inc(XNCR) | COM | 98401F105 | $4.3K | 225,000 | 0.0% |
| Cooper Companies Inc (The) | COM | 216648402 | $4.3K | 25,000 | 0.0% |
| Dexcom Inc(DXCM) | COM | 252131107 | $4.4K | 55,000 | 0.0% |
| Zeltiq Aesthetics Inc | COM | 98933Q108 | $4.4K | 160,000 | 0.0% |
| Omnicell Inc(OMCL) | COM | 68213N109 | $4.4K | 128,537 | 0.0% |
| Intra-Cellular Therapies Inc(ITCIEUR) | COM | 46116X101 | $4.5K | 115,000 | 0.0% |
| Ariad Pharmaceuticals Inc | COM | 04033A100 | $4.6K | 625,000 | 0.0% |
| Cerner Corp(CERNCHF) | COM | 156782104 | $4.7K | 81,000 | 0.0% |
| Medivation Inc | COM | 58501N101 | $4.8K | 80,000 | 0.0% |
| Vertex Pharmaceuticals Inc(VRTX) | COM | 92532F100 | $5.2K | 60,000 | 0.0% |